Cargando…
Enteropeptidase inhibitor SCO-792 effectively prevents kidney function decline and fibrosis in a rat model of chronic kidney disease
BACKGROUND: Inhibiting enteropeptidase, a gut serine protease regulating protein digestion, suppresses food intake and ameliorates obesity and diabetes in mice. However, the effects of enteropeptidase inhibition on kidney parameters are largely unknown. Here, we evaluated the chronic effects of an e...
Autores principales: | Katayama, Yuko, Sugama, Jun, Suzuki, Tomohisa, Ishimura, Yoshimasa, Kobayashi, Akihiro, Moritoh, Yusuke, Watanabe, Masanori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8008362/ https://www.ncbi.nlm.nih.gov/pubmed/33351150 http://dx.doi.org/10.1093/ndt/gfaa349 |
Ejemplares similares
-
An Exploratory Randomized Trial of SCO-792, an Enteropeptidase Inhibitor, in Patients With Type 2 Diabetes and Albuminuria
por: Kagawa, Tomoya, et al.
Publicado: (2022) -
SCO‐792, an enteropeptidase inhibitor, improves disease status of diabetes and obesity in mice
por: Yashiro, Hiroaki, et al.
Publicado: (2019) -
Discovery and characterization of a small‐molecule enteropeptidase inhibitor, SCO‐792
por: Sasaki, Masako, et al.
Publicado: (2019) -
Enteropeptidase inhibition improves kidney function in a rat model of diabetic kidney disease
por: Sugama, Jun, et al.
Publicado: (2020) -
Role of SCO-792, A Novel Enteropeptidase Inhibitor, In the Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis
por: Rashid, Mohammed Y, et al.
Publicado: (2021)